Single-Dose Bioequivalence Study of Rivaroxaban-Containing Medicinal Products in Healthy Volunteers
Therapeutically, new oral anticoagulants (NOACs) are considered to be non-inferior or superior to vitamin K antagonists (warfarin). NOACs are included in current guidelines for the treatment of various cardiovascular diseases. Rivaroxaban medicinal products have been shown to effectively fight throm...
Gespeichert in:
Hauptverfasser: | G. N. Gildeeva (VerfasserIn), A. A. Chaplenko (VerfasserIn), V. I. Yurkov (VerfasserIn), E. S. Stepanova (VerfasserIn) |
---|---|
Format: | Buch |
Veröffentlicht: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2022-10-01T00:00:00Z.
|
Schlagworte: | |
Online-Zugang: | Connect to this object online. |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Ähnliche Einträge
-
Bioequivalence of Rivaroxaban Hard Capsules vs. Film-Coated Tablets in Healthy White Volunteers
von: Agnieszka Gierczak-Pachulska, et al.
Veröffentlicht: (2024) -
Bioequivalence study of generic nirmatrelvir in healthy volunteers
von: R. A. Oseshnyuk, et al.
Veröffentlicht: (2023) -
BIOEQUIVALENCE STUDY OF GENERIC MOLNUPIRAVIR IN HEALTHY VOLUNTEERS
von: V. B. Vasilyuk, et al.
Veröffentlicht: (2023) -
Pharmacokinetic and bioequivalence study of Telzap® Plus fixed-dose combination compared with MikardisPlus® in healthy volunteers after single administration
von: A. L. Khokhlov, et al.
Veröffentlicht: (2023) -
Evaluation of bioequivalence of two tablet forms of lisinopril in healthy volunteers
von: S. A. Altynbekov, et al.
Veröffentlicht: (2013)